Results 11 to 20 of about 28,797 (142)
Pharmaceutics, 2023 Dose recommendations for lamivudine or emtricitabine in children with HIV and chronic kidney disease (CKD) are absent or not supported by clinical data.
Tom G. Jacobs +7 more
doaj +1 more source
Electronic Physician, 2014 Rhabdomyolysis is a serious but rare side effect of Lamivudine treatment. Therefore, appropriate biochemical monitoring should be undertaken when it is used in the treatment of hepatitis B.
Janudin Baharin +2 more
doaj +1 more source
Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B
The Turkish Journal of Gastroenterology, 2016 Background/Aims: Several guidelines recommend the use of tenofovir or entecavir as the first-line treatment for hepatitis B due to the lower resistance rates of these drugs than lamivudine, although lamivudine may still be preferred because of its low ...
Kadri Atay +9 more
doaj +1 more source
Top-Down Synthesis of a Lamivudine-Zidovudine Nano Co-Crystal
Crystals, 2020 Lamivudine (3TC) and zidovudine (AZT) are antiretroviral agents used to manage HIV/AIDS infection. A wet media milling top-down approach was used to develop and produce nano co-crystals of 3TC and AZT.
Bwalya A. Witika +2 more
doaj +1 more source
QUANTITATION OF LAMIVUDINE BY UV SPECTROPHOTOMETRY
Acta Biomedica Scientifica, 2017 HIV infection poses a threat to the existence of humankind as a whole. Currently, lamivudine is widely used in antiretroviral therapy regimens. Modern methods of assessing quality, both in substance and in tablets, are characterized by a number of ...
Y. A. Gonchikova +2 more
doaj +1 more source
Journal of Applied Pharmaceutical Research, 2020 A novel, simple, precise and accurate method developed for the estimation of Lamivudine and tenofovir disoproxil fumarate (TDF) in bulk drug form has been established. Lamivudine and tenofovir are well known drugs and used in treatment of HIV- Ⅰ.
Shweta Sharma +3 more
doaj +1 more source
BMC Infectious Diseases, 2004 Background Lamivudine inhibits replication of both human immunodeficiency virus (HIV) and hepatitis B virus (HBV) and is commonly used as part of antiretroviral therapy. The main limitation in the use of lamivudine is resistant mutation selection.
Arabe Juçara +3 more
doaj +1 more source
Experience with lamivudine treatment for severe acute hepatitis B [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2014 Introduction. Experience with lamivudine treatment for acute severe hepatitis B is limited. Fulminant hepatitis develops in 1% of immunocompetent patients with acute hepatitis B. Objective.
Verhaz Antonija
doaj +1 more source
LIVER TRANSPLANTATION AND HBV INFECTION
Вестник трансплантологии и искусственных органов, 2009 The paper describes the modern approaches in treatment of hepatitis B virus (HBV)-infected patients who underwent liver transplantation. The patients with HBV liver cirrhosis and waiting for orthotopic liver transplantation (OLT) have to receive long ...
O. I. Andreytseva +2 more
doaj +1 more source
THE STUDY OF INFLUENCE OF PREPARATION «COMBIVIR» ON CARBOHYDRATE AND LIPID METABOLISM OF BLOOD SERUM
Современная наука и инновации, 2022 The purpose of this study was to evaluate the effect of the drug «Combivir» on indicators of carbohydrate metabolism and serum lipids in the systemic toxicity study conducted in conditions of chronic experiment.
Elena Olegovna Sergeeva +2 more
doaj